InvestorsHub Logo
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Friday, 04/30/2010 9:36:04 AM

Friday, April 30, 2010 9:36:04 AM

Post# of 69
7:34AM ISTA Pharm misses by $0.08, misses on revs; guides FY10 EPS below consensus, revs in-line (ISTA) 4.08 : Reports Q1 (Mar) loss of $0.20 per share, excluding a non-cash warrant valuation gain of $7.2 million, or $0.21 per share, $0.08 worse than the Thomson Reuters consensus of ($0.12); revenues rose 38.7% year/year to $28.3 mln vs the $28.9 mln consensus. Co issues mixed guidance for FY10, sees EPS of at least $0.02 vs. $0.05 Thomson Reuters consensus; sees FY10 revs of $147-165 mln vs. $150.83 mln Thomson Reuters consensus.


surf's up......crikey